NIH-Developed Candidate Dengue Vaccine Shows Promise in Early-Stage Trial

News   Apr 29, 2013

 
NIH-Developed Candidate Dengue Vaccine Shows Promise in Early-Stage Trial
 
 
 

RELATED ARTICLES

Some Immune Cells May Help Tumors Instead of Destroying Them

News

New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.

READ MORE

Oligonucleotide Drug Producers Report on Drug Impurities

News

A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities.

READ MORE

IDEX Health & Science Announces Acquisition of New Microfluidics Company

News

IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE